Kingstone Capital Partners Texas, LLC Abb Vie Inc. Transaction History
Kingstone Capital Partners Texas, LLC
- $624 Billion
- Q2 2025
A detailed history of Kingstone Capital Partners Texas, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kingstone Capital Partners Texas, LLC holds 3,134,454 shares of ABBV stock, worth $600 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,134,454Holding current value
$600 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
4,271Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$33.3 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.3 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.88 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $339B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...